April 22, 2024

Bio-Europe 2025

Bio-Europe 2025

Europe’s premier partnering event

November 3–5, 2025 | Vienna, Austria

November 11–12, 2025 | Digital Partnering

BIO-Europe will host over 29,000 one-to-one meetings. The powerful partneringONE platform allows you to effortlessly and efficiently search for your most ideal partners. BIO-Europe will feature a distinguished lineup of speakers, including leading experts and visionaries from the biotech and pharma industries, who will take you on a journey of the past 30 years of experiences, partnerships and innovation and envision trends in the next 30 years to come.


BioRN Members get a 15 %  discount.

Registration Rates

EARLY BIRD:
by July 25
by Sept. 12 by Oct. 17 by Nov. 1 on-site DIGITAL PASS w/o on-site access
R&D Company, Investor, Government €       2.695,00  €        2.895,00  €   3.195,00  €   3.495,00  €   3.795,00  €        1.695,00
Biotech & Academics Pre-Revenue Offer TWO registrations for the price of ONE. Deadline to apply: Oct. 27
Service Provider  €       3.395,00  €        3.595,00  €   4.295,00  €   4.595,00  €   4.895,00  €        2.695,00
Young Innovator Rate €           795,00  €            995,00  €   1.195,00  €   1.195,00  €   3.795,00

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

Important: Those companies that have booked a stand participation via the German Pavilion will continue to receive their tickets at the lower R&D / Investor / Government rate. Registration information will be shared directly by the organizing company at a later date.


Please visit the German Pavilion @ BioEurope Fall 2025 in Vienna

Germany@BioEurope Wien 2025

register now

Our latest News

discover more
New Member: Welcome in our cluster to Fab’ulous SAS

New Member: Welcome in our cluster to Fab’ulous SAS

Fabulous accelerates antibody discovery with a fully computational, AI-powered approach that delivers preclinical ready human antibodies in just 3–5 days. Starting from your scientific problem, it designs candidates using curated human sequence data and in silico maturation to mimic natural immune evolution. This process enhances affinity, thermostability, and expression while reducing off-target binding. Each sequence […]

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

AGC Biologics’ Heidelberg Site Supplies Drug Substance for Phase II Studies of Valneva’s Tetravalent Shigella Vaccine Candidate

SEATTLE AND HEIDELBERG – July 29, 2025 – AGC Biologics, your friendly CDMO expert, today announced a development and manufacturing services agreement with specialty vaccine company Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) to supply drug substance for an investigational four-valent Shigella bioconjugate vaccine at the CDMO’s Heidelberg facility.   Valneva exclusively licensed the vaccine candidate from LimmaTech Biologics AG, which […]

From bench to code: collaboration unlocks insights into Alzheimer’s disease

From bench to code: collaboration unlocks insights into Alzheimer’s disease

How a chance encounter at a scientific conference resulted in a fruitful cross-Atlantic research collaboration In 2023, EMBL-EBI Postdoctoral Fellow Iguaracy Pinheiro de Sousa presented his bioinformatics work on how cells communicate within the heart, as part of the Network Biology meeting in Cold Spring Harbour, New York. “I met Yifei Cai during the opening […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp